MG Health’s cultivation facilities are laid out and its QA/QC systems are designed in accordance with Good Agricultural Practice principles.
Growing high-quality organic biomass is best achieved by employing experienced staff, experienced in the cultivation of cannabis in various environments, namely indoor, greenhouse and open air.
With quality and consistency of the medical cannabis product being of greater importance to MG Health than production yield, expertise is required to adapt the cultivation techniques to compensate for the local environment and seasonal changes.
The challenge is producing a consistent end-product
Cultivating a high quality and consistent biomass from a natural source, is necessary to set the platform for the manufacture of a consistent end-product with a stable chemical profile and potency.
These processes have been designed on a scale that allows for future growth of the business without compromising quality.
Drying & processing system
Uniquely designed drying and processing systems ensure that the integrity of the plant oils is retained and enhanced through the extraction process.
Quality management system
Each step is carefully monitored by an integrated quality management system to ensure batch consistency, stability and compliance to quality standards.
Environmental awareness is built into the MG Health’s ethos and all by-products of the extraction process are reclaimed and put to use in the cultivation processes.
The MG Health Facility has been designed in accordance with EU GMP principles, including HEPA filtration, pressurization, dehumidification, temperature control and process flow controls, whilst natural prevention techniques are used for the control of mould, mildew and mites.
Crude Extract is considered as pharmaceutical API (Active Pharmaceutical Ingredient) and is processed in the MG Health facility into a number of dosage forms and formats.
All final products undergo full spectrum testing, including testing for insecticides, mycotoxins, active ingredient assay and the like.
In line with requirements for GMP, full traceability is maintained, from the phenotype to the final product.
All compliance testing and analysis of MG Health product is conducted by LuCan Laboratories (Pty) Ltd (‘LuCan Labs’). LuCan Labs is an independent testing facility leading the way in Africa through extensive quality control, conducting various testing procedures including water testing but with the main focus on the testing and analysis of cannabis and cannabis products, in various forms.
LuCan Labs is fully equipped to test any form of cannabis including flower, crude, edibles, tinctures and distillates.
Customers are supplied with Certificates of Analysis (COA) encompassing the results of the tests conducted, the main objective of the comprehensive testing conducted being to ensure that customers have peace of mind that their product complies with public safety standards and required standards are met.
LuCan Labs operate under strict confidentiality and maintain a secure location with access control via security in a main building and two biometric access control points before entry into the main laboratory.
For more information about LuCan Labs, visit www.lucan.com